Research and Markets has announced the addition of the "Gonorrhoea Pipeline Highlights - 2017" drug pipelines to their offering.

This report, Gonorrhoea Pipeline Highlights - 2017, provides most up-to-date information on key pipeline products in the global Gonorrhoea market. It covers emerging therapies for Gonorrhoea in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Gonorrhoea pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Gonorrhoea pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Gonorrhoea pipeline products by the company.

Short-term Launch Highlights:

Find out which Gonorrhoea pipeline products will be launched in the US and Ex-US till 2020.

Key Topics Covered:

1. Gonorrhoea Pipeline by Stages

2. Gonorrhoea Pipeline by Drug Class

3. Gonorrhoea Pipeline by Company

4. Gonorrhoea Phase 3 Clinical Trial Insights

5. Gonorrhoea Phase 2 Clinical Trial Insights

6. Gonorrhoea Phase 1 Clinical Trial Insights

7. Gonorrhoea Preclinical Research Insights

8. Gonorrhoea Discovery Stage Insights

9. Appendix

10. Research Methodology

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/gv9m7f/gonorrhoea